Nerac

Nerac IPDex™
Revealing Insights into Technology Risk and Innovation Rank

Are you getting the return you want on your technology investments?

How can you assess if you are over-exposed in a particular technology area?

How do you demonstrate the merits of your technology to the review board to secure future liquidity?

Nerac has developed a methodology that leverages our core expertise in patent landscape and market research to help quantify the innovation and risk for your company’s investments.
Learn more here.

Medical Device/Regulatory Support
Nerac’s team of analysts provide regulatory support to medical device manufacturers during and after market approval, with a focus on EU regulatory requirements. Nerac regulatory services include State of the Art Literature Review, Clinical Literature Evaluations, EU Clinical Evaluation Reports (CERs), and Vigilance Alerting/Period Literature Searches in support of Post-Market Surveillance Activities, as an input to risk management activities, and for ongoing preparation for CER updates.
Learn more here.

Recession: The Mother of All Innovation

As companies grapple with rising interest rates and tight cash flow, entrepreneurs, R&D managers, and startups are asking what are the right technologies to back? How do innovators quantify opportunity, value, and risk? More than just a patent landscape, Nerac has developed a methodology to help answer these questions.

Access the article here.